A Stanford medical student uses images from pathology to tell a story about the medical ethics of screening for prostate cancer.
PSA testing is an important tool to spot prostate cancer, but it remains a bit confusing. Stanford urologist James Brooks clarifies some misconceptions.
A team of Stanford scientists have devised a new imaging technology that harnesses ultrasound and photoacoustics to detect prostate cancer earlier.
Pioneering immunotherapy drug Provenge is enjoying a revival, thanks to a large new clinical trial that will test it in men with early prostate cancer.
The U.S. Preventive Services Task Force is now recommending that men aged 55 to 69 should talk with their doctors about prostate-specific antigen screening.
This Stars of Stanford Medicine Q&A features Tanya Stoyanova, PhD, who studies prostate cancer.
Men with localized prostate cancer face good odds: Their relative five-year survival rate is nearly 100 percent. However, men with metastatic disease -- prostate cancer …
Improved methods for analyzing patient medical records support the suspicion that a common cancer treatment may increase the risk of dementia. Such methods may soon …
Many men with prostate cancer have slow-growing tumors that don't require aggressive treatments such as surgery or radiation therapy, whereas others have rapidly-growing prostate tumors …
The number of newly diagnosed stomach cancer cases in the United States is less than a tenth of the number of prostate cancer cases or …
This month is National Prostate Cancer Awareness Month, and Stanford urologic oncologists are sharing their knowledge about prostate cancer diagnosis and treatment, both online and …
We've partnered with Inspire, a company that builds and manages online support communities for patients and caregivers, to launch a patient-focused series here on Scope. …
Previous research has shown that regularly drinking coffee could offer a number of health benefits, including reducing prostate cancer risk, improving symptoms related to Parkinson's …
To watch and wait, or operate? There's quite a bit of confusion, and a variety of differing opinions from the medical community, regarding prostate cancer …
Recovering from a severe illness can take a toll on a person. For older men who have survived prostate cancer and undergone androgen deprivation therapy, …
Prostate cancer is the second leading cause of cancer death among men, and it's something of an enigma. Unlike cancer in most other sites, tumors …
